x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD"s CME activities. Our topics span cardiology, diabetes, oncology, women"s health and more. And our CME library is continuously growing, every quarter.

science & medicine medicine

All Episodes

00:00:00

Prevalence and Burden of PTSD in Women: Focus on...

CME/CE ·

2024/10/15

Guest: Joseph F. Goldberg, MD Guest: Roger McIntyre, MD Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with

en

00:00:00

Modeling Activity: Quality Conversations With...

CME/CE ·

2024/10/15

Guest: Roger McIntyre, MD Guest: Joseph F. Goldberg, MD Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with

en

00:00:00

Setting the Stage: Unmet Needs in the Treatment of...

CME/CE ·

2024/10/15

Guest: Joseph F. Goldberg, MD Guest: Roger McIntyre, MD Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with

en

00:00:00

Role of PCP & Ob-Gyn With Women at Risk for PTSD:...

CME/CE ·

2024/10/15

Host: Joseph F. Goldberg, MD Guest: Roger McIntyre, MD Patients with PTSD suffer from a range of psychiatric symptoms that severely reduce their quality of life. PTSD has proven to not only be a complicated diagnosis, but also one that has a low index of suspicion. Many patients are not screened for PTSD, and those who are diagnosed often gain little benefit from currently available treatments. Join us as these issues are dissected by Drs. Joseph Goldberg and Roger McIntyre, with

en

00:00:00

Bridging Distances in PAH: Bringing Best Practices to...

CME/CE ·

2024/10/11

Host: Jean M. Elwing, MD Host: Nicholas Kolaitis, MD, MAS Guest: Katharine Clapham, MD Pulmonary Arterial Hypertension (PAH) requires a personalized, multidisciplinary approach, which is often lacking in remote regions due to limited access to specialized care and resources. The scarcity of specialized PH centers forces reliance on general practitioners, further hampered by geographic isolation and constrained resources. These limitations make it difficult for healthcare

en

00:00:00

Advancing Cystic Fibrosis: Addressing Disparities,...

CME/CE ·

2024/10/11

Host: Denis Hadjiliadis, MD, MHS, PhD Guest: Gregory S. Sawicki, MD, MPH Guest: Alexandra Wilson, MS, RDN, CDE Guest: Susanna A. McColley, MD Cystic Fibrosis (CF) care faces challenges from health disparities, limited access, and unintended bias, affecting patient outcomes. This CME program aims to equip healthcare professionals with the skills needed to overcome these barriers and provide equitable care for all CF patients. It covers telehealth strategies, best practices

en

00:00:00

Bringing Treatment Into Focus: Biomarker-Driven...

CME/CE ·

2024/10/04

Host: David H. Ilson, MD, PhD Guest: Sunnie Kim, MD This educational activity delves into biomarker-driven strategies for first-line therapy in metastatic gastric and gastroesophageal junction (GEJ) cancers. Participants will explore the latest clinical trial data and emerging biomarkers that guide treatment decisions. Our experts emphasize selecting optimal therapies tailored to patient-specific factors and offer strategies for managing treatment-related adverse effects. Tune in

en

00:00:00

Unveiling the Reperfusion Paradox

CME/CE ·

2024/10/02

Guest: Manesh R. Patel, MD Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term consequences of IRI, including the development of heart

en

00:00:00

Biomarkers of the Storm: Decoding IRI’s Signature

CME/CE ·

2024/10/02

Guest: Manesh R. Patel, MD Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term

en

00:00:00

What’s on the Horizon for IRI Management?

CME/CE ·

2024/10/02

Guest: Manesh R. Patel, MD Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term

en

00:00:00

The Heart’s Aftermath: IRI’s Impact on Cardiac...

CME/CE ·

2024/10/02

Guest: Manesh R. Patel, MD Guest: Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC Expert faculty discuss the critical role of cardiac and inflammatory biomarkers in assessing myocardial damage, predicting risk, and monitoring treatment response. The program also explores emerging therapeutic strategies aimed at mitigating ischemia-reperfusion injury (IRI) and reducing the risk of adverse cardiovascular events. Join Drs. Manesh Patel and Deepak Bhatt as they address the long-term

en

00:00:00

ARVO Recap: What’s New in TED

CME/CE ·

2024/09/30

Guest: Fatemeh Rajaii, MD, PhD Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical clinical signs or hyperthyroidism

en

00:00:00

Underlying Mediators of Immune Dysregulation in TED

CME/CE ·

2024/09/30

Guest: Selina McGee, OD, FAAO Guest: Terry J. Smith, MD Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical

en

00:00:00

Diagnostic Challenges of TED: What General Eye Care...

CME/CE ·

2024/09/30

Host: Prem S. Subramanian, MD, PhD Guest: Selina McGee, OD, FAAO Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without

en

00:00:00

TED: Current Treatments, Current Challenges

CME/CE ·

2024/09/30

Host: Prem S. Subramanian, MD, PhD Guest: Terry J. Smith, MD Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical

en

00:00:00

TED: Clinical Trials Spotlight

CME/CE ·

2024/09/30

Host: Prem S. Subramanian, MD, PhD Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical clinical signs or

en

00:00:00

The Burden of TED

CME/CE ·

2024/09/30

Guest: Terry J. Smith, MD Guest: Selina McGee, OD, FAAO Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical

en

00:00:00

The Future of TED

CME/CE ·

2024/09/30

Guest: Fatemeh Rajaii, MD, PhD Guest: Selina McGee, OD, FAAO Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical

en

00:00:00

Diagnostic Challenges of TED: What Endocrinologists...

CME/CE ·

2024/09/30

Guest: Fatemeh Rajaii, MD, PhD Guest: Terry J. Smith, MD Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without typical

en

00:00:00

Diagnostic Challenges of TED: What Eye Care...

CME/CE ·

2024/09/30

Host: Prem S. Subramanian, MD, PhD Guest: Fatemeh Rajaii, MD, PhD Thyroid eye disease (TED) is a relatively rare disease that is challenging to diagnose and has limited treatment options. TED may be overlooked by clinicians due to the wide range of clinical manifestations, ranging from dry eye disease to diplopia, proptosis, eyelid retraction, and sight-threatening optic neuropathy. Although TED is often associated with thyroid disorders such as Graves’ disease, cases without

en

267 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事